Related Experiment Video
Updated: May 19, 2026

13:18
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Baseline Factors Predictive of SLT Response: A Prospective Study
Robin Bruen1, Mark R Lesk, Paul Harasymowycz
1Department of Ophthalmology, University of Montreal, Montreal, QC, Canada.
Journal of Ophthalmology
|August 18, 2012
Summary
Selective Laser Trabeculoplasty (SLT) effectively lowers intraocular pressure (IOP), especially with higher baseline IOP. However, prior prostaglandin analogue use may reduce SLT
Area of Science:
- Ophthalmology
- Glaucoma Research
- Laser Therapy
Background:
- Selective Laser Trabeculoplasty (SLT) is a common treatment for open-angle glaucoma and ocular hypertension.
- Understanding factors influencing SLT efficacy is crucial for patient management.
- Baseline characteristics may impact treatment outcomes.
Purpose of the Study:
- To investigate the response to Selective Laser Trabeculoplasty (SLT).
- To analyze the influence of baseline medical treatment, angle pigmentation, age, diagnosis, and intraocular pressure (IOP) on SLT outcomes.
- To determine predictors of IOP reduction after SLT.
Main Methods:
- Retrospective analysis of 74 eyes from 74 patients undergoing SLT.
- Recording of baseline characteristics including medical treatment and IOP.
- Serial IOP measurements at baseline, 1, 6, and 12 months post-SLT.
- Statistical comparison using two-way ANOVA and Pearson's correlation.
Main Results:
- A mean IOP decrease of -4.67 ± 3.40 mmHg was observed at one year.
- Higher baseline IOP strongly correlated with a greater absolute IOP reduction.
- Pretreatment with prostaglandin analogues was associated with a diminished IOP-lowering effect.
- No significant differences in IOP response were noted based on age, angle pigmentation, gender, or diagnosis.
Conclusions:
- Higher baseline IOP predicts a more substantial IOP reduction following SLT.
- Prostaglandin analogue use prior to SLT may attenuate its IOP-lowering efficacy.
- SLT remains an effective treatment, but patient-specific factors warrant consideration.
